Endo International plc’s Par Pharmaceutical has begun shipping the first generic version of Merz's Cuvposa (glycopyrrolate) 1mg/5ml oral solution in the US, after earlier receiving US Food and Drug Administration approval for the product with 180-day exclusivity.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?